INTRODUCTION
============

Obesity and its related comorbidities have been associated with increased complication rates in patients undergoing autologous breast reconstruction.^[@R1]--[@R13]^ Of the autologous options, the pedicled myocutaneous latissimus dorsi (LD) flap has lower complication rates compared with free tissue transfer, particularly in the obese population.^[@R14]--[@R18]^ However, a traditional LD flap is limited in the volume it can achieve in e. Add Auch as f plfacement or extended dissection have improved volume but add additional risks.^[@R14]f[@R19]--[@R23]^ Implant placement negates a totally autologous reconstruction and is subject to infection, malposition, capsular contracture, and extrusion.^[@R24]^ Extended dissection is associated with higher rates of donor-site wounds, seroma, and lumbar hernia.^[@R25],[@R26]^

Recently, immediate fat grafting has been described to improve the volume that can be achieved with the LD flap.^[@R20],[@R27]--[@R32]^ However, no study has looked specifically at the results of breast reconstruction in the obese population undergoing LD with immediate fat grafting. The aim of this study is to identify whether a difference exists in complication rates among obese patients (body mass index \[BMI\] \> 30 kg/m^2^) undergoing LD with immediate fat grafting versus abdominal-based free tissue transfer for breast reconstruction. To our knowledge, this is the first study directly comparing these autologous breast reconstruction options in obese patients.

PATIENTS AND METHODS
====================

A retrospective review was approved by the institutional review board at Baylor Scott & White Medical Center---Temple to identify patients who underwent autologous breast reconstruction from January 2015 through January 2019. Surgeries were performed by 2 surgeons with uniform surgical and postoperative protocols. Patients were identified by Common Procedural Terminology codes 19361 for LD flaps and 19364 for free tissue transfer.

Patient-identifiable intrainstitutional National Surgical Quality Improvement Program data were used to obtain patient demographics and comorbidities, and chart review was conducted when these data were unavailable. Demographic data included age and BMI. Comorbidities included diabetes (insulin and noninsulin dependent), smoking status within the last year, pulmonary disease, hypertension requiring medication, chronic steroid use, presence of a bleeding disorder, and American Society of Anesthesiologists' (ASA) classification. Timing of breast reconstruction was recorded as either immediate or delayed. Delayed reconstruction also included patients who may have had a tissue expander placed at the time of mastectomy, otherwise known as delayed-immediate reconstruction (Fig. [1](#F1){ref-type="fig"}).^[@R33]^ Data regarding abdominal flap classification, mastectomy type, nonhormonal neoadjuvant chemotherapy, and perioperative requirement of radiotherapy were also collected.

![A 48-year-old woman with BMI 36 kg/m^2^. ASA class 2. The patient had a remote history of left breast invasive ductal carcinoma, for which she underwent lumpectomy and radiation. The patient was subsequently found to be BRCA1 positive and underwent bilateral prophylactic skin sparing mastectomies with immediate placement of bilateral pre-pectoral tissue expanders. (A and B) Right and left oblique views before bilateral prophylactic mastectomies and tissue expander placement. The patient underwent delayed immediate reconstruction with bilateral LD flaps and 460 mL (230 mL right, 230 mL left) immediate fat grafting 3 months post-mastectomy. The patient required 1 revision procedure with fat grafting (200 mL right; 200 mL left). Within this revision, the patient also underwent bilateral brachioplasty, right lateral thoracic dermatolipectomy, and dermatolipectomy to the bilateral breasts for symmetry. The patient did not desire nipple-areolar reconstruction. (C and D) Right and left oblique views of the 9-month final reconstruction result.](gox-8-e2668-g001){#F1}

The World Health Organization's definition of obesity (BMI ≥ 30) was used as the inclusion criteria. Chart review was conducted to identify which LD cases included immediate fat grafting and exclude all others. Free tissue transfers that were not abdominal-based were excluded.

Incidents of postoperative complications were identified by chart review and were divided into minor or major surgical complications (recorded per breast and respective donor site) and medical complications (per patient). Minor complications were defined as those of the donor site and reconstruction site that required management in the outpatient setting: donor-site complications, breast wound healing issues, infection requiring oral antibiotics, and seroma requiring aspiration. Major complications were those that required return trips to the operating room: donor-site complications, hematoma, flap loss, infection/abscess, breast wound debridement, and flap thrombosis. Medical complications were included if they required inpatient admission but no surgical intervention. A pooled variable was generated to include major complications requiring reoperation or medical complications requiring admission. Abdominal bulge or hernias requiring surgical intervention during the follow-up period were also noted for free tissue transfers.

Additional data were collected to characterize the procedures and perioperative period. Outcomes of interest included mean operative duration, volume of fat grafted immediately to LD flaps, number of breast and donor-site revisions, volume of revision fat grafting, mastectomy weight, requirement of implant during revision, hospital length of stay, and time of drain in situ.

Surgical Technique
------------------

The included LD with immediate fat grafting patients were marked preoperatively with the patient in an upright position. The skin paddle was designed transversely to lie within natural creases in the back and maximize the skin paddle's size and volume. Fat harvest donor sites for LD with immediate fat grafting commonly included the abdomen, flanks, and medial and lateral thighs and were based on each patient's individual body habitus and fat distribution. Details of the flap harvest have been described previously.^[@R34]^ The LD donor site was closed directly with the use of progressive tension sutures to obliterate empty space, and 2 drains were routinely placed at each donor site. Fat grafting recipient sites for LD with immediate fat grafting included the LD muscle, flap skin paddle, pectoralis major and serratus muscles, and mastectomy skin flaps. Selection of fat grafting recipient sites has also been described previously.^[@R32]^

For patients who underwent free tissue transfer, abdominal flap markings were made preoperatively with the patient in sitting, standing, and flexed positions. The majority of flaps were deep inferior epigastric artery perforator flaps. Flaps were converted to muscle-sparing transverse rectus abdominis myocutaneous flaps or transverse rectus abdominis myocutaneous flaps as needed based on each patient's vascular anatomy. Free tissue transfer donor sites were closed with progressive tension sutures to obliterate empty space, and 1 drain was routinely placed on each side of the abdomen. Fascial defects were closed with permanent sutures, and a synthetic mesh was used as needed for fascial defects.

For postoperative analgesia, donor sites for the LD with immediate fat grafting and the free tissue transfer groups were routinely injected with an analgesic cocktail consisting of 60 mL of 0.25% bupivacaine, 50 mcg dexmedetomidine, 30 mg ketorolac, and 4 mg dexamethasone mixed in 250 mL of normal saline. This was injected in a transversus abdominis plane for abdominal donor sites and in a subcutaneous, peri-incisional plane for back donor sites.

Statistical Analysis
--------------------

Sample characteristics were described using descriptive statistics. Frequencies and percentages were used to describe categorical variables, while means, SDs, medians, and ranges were used for continuous variables. Nonparametric univariate analysis was conducted using Fisher exact test for categorical variables and Mann--Whitney *U*-test for continuous variables. Mastectomy type and obesity were analyzed using the χ^2^ test. All analyses were 2-tailed and statistical significance was considered at *P* ≤ 0.05.

RESULTS
=======

Patients and Characteristics
----------------------------

A total of 149 breasts in 82 obese patients met final inclusion criteria. Patients' mean age was 51 years and mean BMI was 35.7 kg/m^2^. It should be noted that while the BMI between groups was similar, the BMI ranged widely. The highest BMI in the LD with immediate fat grafting group was 52.6 kg/m^2^, while the highest BMI in the free tissue transfer group was only 35.2 kg/m^2^.

Procedure-specific patient characteristics are reported in Table [1](#T1){ref-type="table"}. Sixteen patients (26 breasts) underwent LD with immediate fat grafting, while 66 patients (123 breasts) underwent free tissue transfer. Patients undergoing LD with immediate fat grafting tended to be older. Mean BMIs were comparable between the LD with immediate fat grafting and free tissue transfer patients. The majority of patients in both groups underwent skin-sparing mastectomy and delayed reconstruction (Figs. [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}). Of these patients, 2 who received LD with immediate fat grafting underwent delayed-immediate reconstruction with tissue expander placement at the time of mastectomy (Fig. [1](#F1){ref-type="fig"}). No significant difference was observed in the number of patients receiving neoadjuvant chemotherapy or radiotherapy. All radiation was completed before definitive autologous reconstruction.

###### 

Patient Demographics and Comorbidities

                             LD + Immediate Fat Grafting   Free Tissue Transfer   *P*                               
  -------------------------- ----------------------------- ---------------------- ------------- ------------------- -----------
  Patients ϕ                 16                                                   66                                
  Breasts                    26                                                   123                               
  Age                        56.8 ± 12.4                   54 (37--79)            49.9 ± 9/9    50 (29--74)         0.060
  BMI\*                      37.6 ± 5.5                    36.8 (30.0--52.6)      35.2 ± 3.2    34.8 (30.0--35.2)   0.109
   WHO class I               4                             25.0%                  34            51.5%               0.161
   WHO class II              10                            62.5%                  27            40.9%               
   WHO class III             2                             12.5%                  5             7.6%                
  Laterality                                                                                                        0.064
   Bilateral                 10                            62.5%                  57            86.4%               
   Unilateral                6                             37.5%                  9             13.6%               
  Reconstruction timing§                                                                                            \< 0.001
   Immediate†                1                             3.8%                   58            47.2%               
   Delayed‡                  25                            96.2%                  65            52.8%               
  Flap classification                                                                                               ---
   TRAM                      ---                           ---                    1             0.8%                
   MS-TRAM                   ---                           ---                    59            47.9%               
   DIEP                      ---                           ---                    63            51.2%               
  Mastectomy type                                                                                                   0.622
   Partial                   0                             0%                     2             1.9%                
   NSM                       0                             0%                     4             3.7%                
   SSM                       19                            86.4%                  93            86.9%               
   MRM                       3                             13.6%                  7             6.5%                
   Radical                   0                             0%                     1             0.9%                
  Neoadjuvant chemotherapy   6                             42.9%                  14            22.6%               0.177
  Radiotherapy               4                             16.7%                  16            13.3%               0.747
  Diabetes                   7                             43.8%                  16            24.2%               0.133
   Insulin-dependent         3                             4.5%                   0             0%                  1.000
  Smoker                     2                             12.5%                  10            15.2%               1.000
  COPD                       0                             0%                     3             4.5%                1.000
  Hypertension               10                            62.5%                  31            47.0%               0.404
  Chronic steroid use        2                             12.5%                  2             3.0%                0.169
  Bleeding disorder          0                             0%                     2             3.0%                1.000
  ASA class \> 2             14                            87.5%                  37            56.1%               **0.023**
  Follow-up time (months)    23.2 ± 11.0                   23 (6--41)             36.1 ± 13.8   34 (13--62)         **0.002**

\*WHO obesity classification: class 1, 30--34.9kg/m^2^; class 2, 35--39.9 kg/m^2^; class 3, \>40 kg/m^2^.

†Immediate reconstruction includes reconstructions performed within the same operation as the mastectomy.

‡Delayed reconstruction includes reconstructions performed in an operation subsequent to the mastectomy.

§Reconstruction timing, mastectomy type, and radiotherapy data points expressed per breast.

LD, latissimus dorsi; BMI, body mass index; WHO, World Health Organization; TRAM, transverse rectus abdominis myocutaneous; MS-TRAM, muscles sparing transverse rectus abdominis myocutaneous; DIEP, deep inferior epigastric perforator; NSM, nipple sparing mastectomy; SSM, skin sparing mastectomy; ASA, American Society of Anesthesiologists.

![A 49-year-old woman with BMI 37 kg/m^2^ and past medical history of diabetes mellitus and hypertension. ASA class 3. The patient underwent bilateral skin sparing mastectomies with left axillary lymph node dissection and adjuvant chemoradiation for invasive ductal carcinoma of the left breast. (A and B) Right and left oblique views post-mastectomy and post-radiation to the left breast. The patient underwent delayed reconstruction with bilateral LD flaps and 500 mL (200 mL right, 300 mL left) immediate fat grafting 9 months after completing radiation. The patient required 2 revision procedures with fat grafting (total 580 mL right; 350 mL left) and dermatolipectomy to the bilateral breasts for symmetry. The patient did not desire nipple-areolar reconstruction. (C and D) Right and left oblique views of the 1-year final reconstruction result. (E and F) LD donor site---preoperative and 4 months postoperative.](gox-8-e2668-g002){#F2}

![A 47-year-old woman with BMI 38 kg/m^2^ and past medical history diabetes mellitus, hypertension, and pulmonary disease. ASA class 3. The patient underwent bilateral skin sparing mastectomies for left breast IDC. The patient did not require adjuvant radiation. (A and B) Right and left oblique views 3 months post-mastectomy. The patient underwent bilateral LD flaps and 200 mL (100 mL right, 100 mL left) immediate fat grafting 5 months post-mastectomy. The patient required 1 revision procedure for dermatolipectomy to the bilateral breasts for symmetry. The patient did not require any additional fat grafting after the primary reconstruction. (C and D) Right and left oblique views of the 2-year final reconstruction result after nipple areolar reconstruction.](gox-8-e2668-g003){#F3}

Importantly, patients in the LD with immediate fat grafting group tended to be significantly more comorbid according to ASA class (ASA class \> 2; 87.5% versus 56.1%; *P* = 0.023). No significant differences existed in prevalence of diabetes, hypertension, smoking status, pulmonary disease, chronic steroid use, or bleeding disorders. All patients had a minimum follow-up of 6 months, but the duration was longer in the free tissue transfer cohort (mean \[SD\], 36.1 \[13.8\] versus 23.2 \[11.0\] months; *P* = 0.002).

Procedure characteristics appear in Table [2](#T2){ref-type="table"}. Average operative durations for bilateral free tissue transfers were 2.1 hours longer (*P* = 0.018), and those for unilateral transfers were 2.6 hours longer than LD with immediate fat grafting (*P* = 0.019). Mean hospital stay of 2.05 days was significantly (*P* \< 0.001) longer for free tissue transfers. No significant difference for duration of drains (donor site or breast) in situ was observed between groups. Mastectomy weight was similar between groups. Of note, in the LD with immediate fat grafting group, a mean of 188.9 mL of autologous fat was grafted immediately during primary reconstruction. Both groups required a similar number of subsequent breast revisions, with a median of 1 revision each. The free tissue transfer donor site required significantly more subsequent revisions than the donor site for LD with immediate fat grafting (0.78 \[0.82\] versus 0.23 \[0.59\] times; *P* \< 0.001). The LD with immediate fat grafting group required a larger volume of fat grafting during subsequent revisions (194.3 \[168.4\] versus 108.8 \[135.1\] mL; *P* = 0.01). This trend was also noted for the total sum of fat grafting volume received, including during the index procedure for the LD with immediate fat grafting group (*P* = 0.01). Eight free tissue transfer patients required augmentation with implants compared with zero LD with immediate fat grafting patients.

###### 

Procedure Characteristics

                                     LD + Immediate Fat Grafting   Free Tissue Transfer   *P*                               
  ---------------------------------- ----------------------------- ---------------------- --------------- ----------------- --------------
  Operative duration (minutes)\*                                                                                            
   Unilateral cases                  294.4 ± 80.3                  282 (205--403)         448.1 ± 76.6    474 (299--533)    **0.019**
   Bilateral cases                   482.4 ± 104.7                 477 (329--666)         608.0 ± 154.3   596 (342--933)    **0.018**
  Length of stay (days)              2.6 ± 1.4                     2 (1--6)               4.65 ± 1.6      4 (2--9)          **\< 0.001**
  Drain time (days)                  17.3 ± 5.8                    16 (10--29)            16.3 ± 6.3      14 (4--34)        0.341
  Mastectomy weight (g)              956.7 ± 286.8                 921 (590--1642)        864.1 ± 336.9   817 (183--1788)   0.161
  Volume immediate fat graft (mL)    188.9 ± 92.2                  200 (60--420)          ---             ---               ---
  Presence of breast revision        20                            76.9%                  88              71.5%             0.638
  No. breast revisions†              1.15 ± 0.881                  1 (0--3)               1.19 ± 1.035    1 (0--4)          0.916
  No. donor-site revisions           0.23 ± 0.59                   0 (0--2)               0.78 ± 0.82     1 (0--3)          \< 0.001
  Volume subsequent fat graft (mL)   194.3 ± 168.4                 178 (0--580)           108.8 ± 135.1   80 (0--675)       **0.01**
  Total fat graft volume (mL)        383.2 ± 174.8                 355 (100--780)         108.8 ± 135.1   80 (0--675)       0.01
  Requirement of implant             0                             0%                     8               6.5%              0.351

\*Operative duration and length of stay expressed per patient.

†Number of breast revisions excludes nipple reconstruction procedures.

LD, latissimus dorsi.

Complication data are demonstrated in Table [3](#T3){ref-type="table"}. The total number of minor complications between groups was similar. In contrast, free tissue transfers resulted in significantly more major complications (20.3% versus 3.8%; *P* = 0.048). Delayed wound healing of the breast requiring in-office debridement was the most common individual minor complication in both groups. Breast wound healing issues requiring operative debridement were the most common (6.5%) major complication for free tissue transfers. The only major complication for LD with immediate fat grafting was a hematoma necessitating reoperation. More than 10% of free tissue transfer patients were readmitted for nonoperative medical complications in contrast to zero LD with immediate fat grafting patients (*P* = 0.336). Medical complications included venous thromboembolism, myocardial infarction, opioid overdose (requiring reversal with Naloxone), and pneumonia. Free tissue transfer patients were significantly more likely to experience either a reoperation due to a major surgical complication or readmission due to a medical complication (36.4% versus 6.3%; *P* = 0.031). Finally, 4 (6.5%) patients who underwent muscle-sparing transverse rectus abdominis myocutaneous flaps required repair of donor-site-related hernias.

###### 

Minor, Major, and Medical Complications

                                                                     LD + Immediate Fat Grafting   Free Tissue Transfer   *P*           
  ------------------------------------------------------------------ ----------------------------- ---------------------- ----- ------- -------
  Minor surgical complication, per breast\*                          7                             26.9%                  32    26.0%   1.000
   Donor site‡                                                       1                             3.8%                   9     7.3%    1.000
   Delayed wound healing (breast)                                    3                             11.5%                  19    15.4%   0.767
   Infection (breast)                                                1                             3.8%                   4     3.3%    1.000
   Fluid collection (breast)                                         2                             7.7%                   1     0.8%    0.079
  Major surgical complication requiring reoperation, per breast      1                             3.8%                   25    20.3%   0.048
   Donor site§                                                       0                             0.0%                   5     4.1%    0.587
   Hematoma (breast)                                                 1                             3.8%                   3     2.4%    0.540
   Flap loss (breast)                                                0                             0.0%                   4     3.3%    1.000
   Infection/abscess (breast)                                        0                             0.0%                   4     3.3%    1.000
   Wound (breast)                                                    0                             0.0%                   8     6.5%    0.351
   Flap thrombosis                                                   0                             0.0%                   1     0.8%    1.000
  Medical complication requiring readmission†                        0                             0.0%                   7     10.6%   0.336
  Patients experiencing any major medical or surgical complication   1                             6.3%                   24    36.4%   0.031
  Hernia requiring surgical repair†                                  ---                           ---                    4     6.50%   

\*Minor, major, and individual surgical complications analyzed per breast.

†Medical complications and hernia formation analyzed per patient.

‡Minor donor-site complications included infection, seroma, and wound separation.

§Major donor-site complications included infection, hematoma, and wound separation.

DISCUSSION
==========

The effects of obesity on breast reconstruction have been well described. However, a consensus on the best reconstructive modality for the obese population has not been reached. In a national review of 12,986 patients who underwent breast reconstruction, Hanwright et al.^[@R35]^ demonstrated that obese patients who underwent tissue expander reconstruction experienced fewer surgical and medical complications as well as fewer reoperations than those who underwent autologous reconstruction. Conversely, in a single-center review of 700 patients, Garvey et al.^[@R36]^ demonstrated that obese patients experience higher failure rates with implant reconstruction than with autologous free-flap techniques. Nonetheless, obesity has been shown to significantly increase perioperative, postoperative, and medical complications, regardless of reconstructive modality.^[@R11],[@R36]^

Whether chosen by surgeon selection or patient preference, autologous breast reconstruction should aim to minimize complications, achieve an esthetic result, and offer an acceptable postmastectomy quality of life. A patient-individualized approach is necessary to choose the best autologous option. Microsurgical advances have led to a variety of flap options for free tissue transfer.^[@R28],[@R37]--[@R42]^ Despite these advances, surgeons need to proceed judiciously and on a case-by-case basis because a variety of patient characteristics may be relative contraindications to free tissue transfer.^[@R13],[@R43],[@R44]^ These contraindications include obesity, diabetes, smoking history, bleeding or clotting disorders, and prior abdominal surgeries.

The pedicled LD has been described as an excellent autologous alternative to free tissue transfer.^[@R7],[@R14]--[@R18],[@R35]^ The versatility and reliability of the LD flap make it a reasonable option for nearly any patient.^[@R14]^ However, the LD is limited by the volume it can achieve. In the past, this constraint was addressed by extending the flap dissection and, if needed, placing an implant. To avoid these modifications and their associated morbidity, immediate fat grafting has been described to augment the volume.

The present study demonstrated multiple advantages of LD with immediate fat grafting over abdominal-based free tissue transfer for obese patients. Despite the LD with immediate fat grafting group having a higher ASA class, similar minor complication rates were observed between groups. These complications, all managed in the outpatient setting, occurred at similar rates in other large retrospective studies.^[@R1]--[@R3],[@R6],[@R11],[@R16]^

Donor-site morbidity in LD with immediate fat grafting was also favorable as compared to the free tissue transfer donor site. Dissection and transfer of the LD muscle is generally well tolerated with minimal to no long-term loss of shoulder function.^[@R45]--[@R47]^ Of note, seroma is the complication most frequently encountered in LD donor sites.^[@R26]^ The absence of this complication in our cohort is likely related to the authors' flap design, use of progressive tension sutures to eliminate empty space, and placement of 2 drains at each LD donor site.^[@R19],[@R32]^ On the contrary, 14 (11.4%) free tissue transfer patients in the present study developed donor-site complications, 5 (4.1%) of which required reoperation. Donor-site complications, hernia, or abdominal bulge following free tissue transfer are significant and associated with increased health care costs, which are even higher among obese patients.^[@R2],[@R48]^

Collectively, patients in the free tissue transfer group were nearly 6 times more likely to require a reoperation or inpatient admission for medical complications. Medical complications add significant morbidity to breast reconstruction and highlight another important contrast in safety profile between procedures. The discrepancy may be related to the longer exposure to general anesthesia (2.1 hours longer in bilateral and 2.6 hours longer in unilateral), longer hospital stays (2.05 days longer), delayed return to activity, or the anatomy of the surgical dissection itself. In a review of autologous breast reconstruction in the United States that corroborated this finding, Pien et al.^[@R49]^ demonstrated longer hospital stays and higher costs in free tissue transfers.

One concern that surgeons may have with volume augmentation through fat grafting is the consideration of fat graft resorption. Nonetheless, in our study, both procedures required a similar number of revisions. The type of revision procedure did, however, differ between groups. LD with immediate fat grafting revisions were to a greater extent directed at continuing to improve volume with additional grafting (194 mL of additional fat on average) versus free tissue transfer (109 mL on average). The free tissue transfer patients required more than 3 times the number of subsequent revisions to the donor site compared with the LD with immediate fat grafting group. This difference was likely related to the impact of delayed wound healing on scar cosmesis and the more conspicuous location of an abdominal scar versus a back scar. Finally, 8 patients who underwent free tissue transfer actually required augmentation with implants, while zero LD with immediate fat grafting patients required implants.

Prior reports of LD with immediate fat grafting have described flap harvest, fat grafting, inset, and donor-site management techniques, all with favorable complication rates. Santanelli et al.^[@R31]^ first described the LD with immediate fat grafting to the flap skin paddle and LD muscle. In 2015, Zhu et al.^[@R32]^ reported on LD with immediate fat grafting and presented an algorithm for selecting recipient sites (LD skin paddle, LD muscle, pectoralis major and serratus, and mastectomy skin flaps) as part of the procedure. Economides et al.^[@R28]^ described volumes up to 359.6 mL and a multilayer injection technique without major complications. In comparison, the amount of fat grafted simultaneously with flap harvest in the present study averaged 186.19 mL per breast. However, importantly, the authors' technique involves harvesting the LD with a large transverse skin paddle. Additional authors have also described their experience with LD with immediate fat grafting.^[@R20],[@R27],[@R29],[@R30]^ However, no prior studies have directly compared the LD with immediate fat grafting to its autologous counterpart, free tissue transfer, in the obese population. This patient population requires larger reconstruction volumes, is at a higher surgical risk, and generally experiences a higher rate of surgical complications with breast reconstruction. LD with immediate fat grafting addresses the issue of volume while offering shorter hospital length of stay, lower costs, and lower rate of flap loss, making it an attractive option for obese patients requiring autologous breast reconstruction.

This study demonstrates significant advantages of LD with immediate fat grafting over free tissue transfer in the obese population. It is however, limited by its retrospective nature. Furthermore, while follow-up time in each group is adequate to fully capture complications data, it is important to acknowledge that follow-up time for the LD with immediate fat grafting group was shorter. Therefore, the number of revisions required may differ with longer-term follow-up, especially considering fat graft resorption. Finally, the study design does not allow for the true impact of the mastectomy on the reconstructive outcomes to be elucidated. Future directions entail expanding the sample size for further review of safety, assessing esthetic and patient satisfaction scores, and analyzing cost-effectiveness.

CONCLUSIONS
===========

LD with immediate fat grafting provides a totally autologous, less morbid reconstruction in patients who are not ideal candidates for microsurgical reconstruction. Obese patients undergoing LD with immediate fat grafting experienced lower rates of major and medical complications, decreased need for donor-site revisions, and shorter operative duration and hospital length of stay. These findings demonstrate that LD with immediate fat grafting is a sound autologous alternative to free tissue transfer in the obese population.
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